{Reference Type}: Letter
{Title}: No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study.
{Author}: Hill RC;Wang Y;Shaikh B;Lipner SR;
{Journal}: J Am Acad Dermatol
{Volume}: 90
{Issue}: 6
{Year}: 2024 Jun 27
{Factor}: 15.487
{DOI}: 10.1016/j.jaad.2024.02.030